Andrew David Levin

CIK: 0001867539

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

VOR

Vor Biopharma Inc.

Director

CLYM

Climb Bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

VOR
Vor Biopharma Inc.
Jun 11, 2026
Award(A)
Stock option (right to buy)
Direct
57.2K shares-
CLYM
Climb Bio, Inc.
Jun 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-
VOR
Vor Biopharma Inc.
Dec 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3K shares-
CLYM
Climb Bio, Inc.
Jun 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	VOR Vor Biopharma Inc.	Award(A) Stock option (right to buy)	57,162	-	-	Direct
Jun 5, 2026	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct
Dec 18, 2025	VOR Vor Biopharma Inc.	Award(A) Stock Option (Right to Buy)	3,000	-	-	Direct
Jun 4, 2025	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct

1-4 of 4 transactions

About Levin Andrew David

Levin Andrew David (SEC CIK 0001867539) files insider reports with the SEC as Director of Vor Biopharma Inc. (VOR) and Director of Climb Bio, Inc. (CLYM).

Signal8 holds 5 ownership filings by Levin Andrew David (1 Form 3, 4 Form 4), filed between Jun 5, 2025 and Jun 12, 2026. Those filings report 4 transactions, from Jun 4, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Levin Andrew David's filings is in WELLESLEY HILLS, MA.

Recent filings by Levin Andrew David

Jun 11, 2026: Grant or award of VOR derivative securities (Form 4, code A).
Jun 5, 2026: Grant or award of CLYM derivative securities (Form 4, code A).
Dec 18, 2025: Grant or award of VOR derivative securities (Form 4, code A).
Jun 4, 2025: Grant or award of CLYM derivative securities (Form 4, code A).

Other insiders filing for Vor Biopharma Inc. (VOR)

RA CAPITAL MANAGEMENT, L.P., 10% Owner
ZACCARDELLI DAVID, Director
Detheux Michel, Director
Namouni Fouad, Director
Joustra Wouter, Director
Kalir Erez, Director

How to read Form 4 transaction codes